News

PREMIER Biosoft International Releases TMA Foresight, a Statistical Tool for Tissue Microarray Data Analysis.

Palo Alto, California -- January 15, 2007, PREMIER Biosoft International today announced the release of its new product, TMA Foresight. TMA Foresight is a statistical tool for tissue microarray data analysis designed especially for pathologists, clinicians and researchers.

TMA Foresight can be used for a wide variety of analysis ranging from simple descriptive statistics that include mean, sum, and variance to more advanced data correlation such as Hierarchical clustering and Kaplan Meier plots. You can explore the relatedness of prognostic marker expression and clinico-pathological variates with the outcome. Cox's Proportional Hazard analysis can be used for prognostic marker identification. Hierarchical clustering can be used to group patients on the basis of a clinico-pathological parameter or a biomarker. Kaplan-Meier plots and log-rank tests can then be used to identify prognostically significant clusters. You can threshold a particular marker and stratify patients into high risk and low risk cohorts.

TMA Foresight not only analyzes data but interprets it, making it a useful tool for pathologists, clinicians and researchers.

TMA Foresight enables easy data pre-processing. It helps map the character data to numeric values with a click of a button. Moreover, the measurement level of each variable can be conveniently defined for use in different statistical analysis.

For details, please visit: http://www.premierbiosoft.com/tissue-microarray/index.html